Verition Fund Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-397,603
| Closed | -$4.12M | – | 2422 |
|
|
2023
Q1 | $4.12M | Hold |
397,603
| – | – | 0.06% | 393 |
|
|
2022
Q4 | $3.97M | Hold |
397,603
| – | – | 0.06% | 333 |
|
|
2022
Q3 | $3.98M | Hold |
397,603
| – | – | 0.04% | 457 |
|
|
2022
Q2 | $3.96M | Hold |
397,603
| – | – | 0.08% | 332 |
|
|
2022
Q1 | $3.93M | Hold |
397,603
| – | – | 0.05% | 364 |
|
|
2021
Q4 | $3.97M | Hold |
397,603
| – | – | 0.03% | 343 |
|
|
2021
Q3 | $3.98M | Sell |
397,603
-89
| -0% | -$890 | 0.03% | 242 |
|
|
2021
Q2 | $4.05M | Hold |
397,692
| – | – | 0.04% | 221 |
|
|
2021
Q1 | $4.06M | Buy |
+397,692
| New | +$4.06M | 0.05% | 180 |
|